RecruitingNCT00243776
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
Studying Tetralogy of Fallot
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Emory University
- Principal Investigator
- Michael E Davis, PhDEmory University
- Enrollment
- 600 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2005 – 2025
Study locations (1)
- Emory University School of Medicine, Atlanta, Georgia, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00243776 on ClinicalTrials.govOther trials for Tetralogy of Fallot
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT06668389Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status TrialThe University of Hong Kong
- RECRUITINGNANCT06822400Investigation of Tetralogy of Fallot in NeonatesBeijing Anzhen Hospital
- ACTIVE NOT RECRUITINGNCT06282926Role of 3D Echocardiography Knowledge-based Reconstruction in ACHDGuy's and St Thomas' NHS Foundation Trust
- RECRUITINGPHASE1NCT04713657Beta-blocker Administration for Cardiomyocyte DivisionWeill Medical College of Cornell University
- ACTIVE NOT RECRUITINGNCT05378386ALTERRA Post-Approval StudyEdwards Lifesciences
- RECRUITINGNCT05122962Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart DiseasesMayo Clinic
- RECRUITINGNCT05288894Repaired Tetralogy of Fallot Italian RegistryAzienda Ospedaliero, Universitaria Ospedali Riuniti
- ACTIVE NOT RECRUITINGNANCT03983512PULSTA Transcatheter Pulmonary Valve Pre-Approval StudyTaewoong Medical Co., Ltd.